Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 4, 2017
Regulation of circulating chromogranin B levels in heart failureFelix M Heidrich, Carolin Melz, Mimi S Buechau, et al.
Biochimica Et Biophysica Acta|October 19, 2013
MiR-134-mediated β1 integrin expression and function in mesenchymal stem cellsDavid M Poitz, Friedrich Stölzel, Laleh Arabanian, et al.
Reviews in Cardiovascular Medicine|January 29, 2022
Evaluation of systemic inflammation in response to remote ischemic preconditioning in patients undergoing transcatheter aortic valve replacement (TAVR)Kun Zhang, Willi Troeger, Matthias Kuhn, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 3, 2014
Increased gene expression of the cardiac endothelin system in obese miceR A Catar, G Muller, A Brandt, et al.
Haematologica|March 4, 2014
MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cellsLaleh S Arabanian, Fernando A Fierro, Friedrich Stölzel, et al.
Biochemistry and Biophysics Reports|November 11, 2021
Spatio-temporal regulation of calpain activity after experimental myocardial infarction in vivoKun Zhang, Melissa M Cremers, Stephan Wiedemann, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 24, 2019
The infarction zone rather than the noninfarcted remodeling zone overexpresses angiotensin II receptor type 1 and is the main source of ventricular atrial natriuretic peptideKun Zhang, Stephan Wiedemann, Martin Dschietzig, et al.
Journal of Clinical Medicine|January 16, 2020
Remote Ischemic Preconditioning Neither Improves Survival nor Reduces Myocardial or Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)Mandy Flechsig, Tobias F Ruf, Willi Troeger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2014
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registryW von Scheidt, C Zugck, M Pauschinger, et al.
Clinical Laboratory|July 13, 2012
Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptideBo Jørgensen, Thomas Bertsch, Hans-Joachim Bröker, et al.
Pageof 29